ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,459 | -13.0% | 70 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $1,677 | +27.3% | 70 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $1,317 | +18.2% | 70 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,114 | +11.4% | 70 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,000 | -50.0% | 70 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $2,000 | 0.0% | 70 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $2,000 | -50.0% | 70 | -68.2% | 0.00% | -50.0% |
Q3 2021 | $4,000 | -55.6% | 220 | -40.5% | 0.00% | -66.7% |
Q2 2021 | $9,000 | -10.0% | 370 | 0.0% | 0.01% | -14.3% |
Q1 2021 | $10,000 | -37.5% | 370 | +23.3% | 0.01% | -46.2% |
Q4 2020 | $16,000 | +33.3% | 300 | 0.0% | 0.01% | +8.3% |
Q3 2020 | $12,000 | – | 300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |